工程大肠杆菌-用于疫苗开发的衍生纳米粒子
Shubing Tang1, Chen Zhao2, Xianchao Zhu1
1Shanghai Reinovax Biologics Co., Ltd., Pudong New District, Shanghai 200135, China.
Vaccines
|November 26, 2024
概括
使用纳米技术开发纳米粒子疫苗可以提高免疫性和安全性. 在大肠杆菌 (E. coli) 中表达的工程蛋白克服了生产挑战,使得负担得起的纳米疫苗成为可能.
科学领域:
- 疫苗学和纳米技术
- 蛋白质工程和生物制造
背景情况:
- 亚单元疫苗是安全的,但往往缺乏强烈的,持久的免疫反应.
- 纳米技术可以通过模仿病原体结构来改进亚单元疫苗.
- 大肠杆菌 (E. coli) 是一个成本效益高的系统用于纳米粒子疫苗生产,但有局限性.
研究的目的:
- 审查提高E. coli蛋白质溶解度和病毒样粒子 (VLP) 组装的策略.
- 探索纳米载体表面的抗原显示和稳定方法.
- 突出生物工程大肠杆菌衍生纳米疫苗的潜力.
主要方法:
- 专注于针对大肠杆菌的分子和蛋白质工程技术.
- 讨论病毒样颗粒 (VLP) 的体外重组.
- 对抗原显示和纳米载体稳定方法的审查.
主要成果:
- 确定了蛋白质工程策略,以改善大肠杆菌中的蛋白质溶解度.
- 概述了有效的 in vitro VLP 重组的方法.
- 讨论了在纳米载体上有效呈现抗原的方法.
结论:
- 生物工程方法可以克服纳米疫苗的大肠杆菌生产挑战.
- 将蛋白质工程与纳米载体设计结合起来,可以产生高效的疫苗.
- 由大肠杆菌衍生的纳米疫苗提供了一条有希望的途径,以负担得起的价格对传染病进行保护.
更多相关视频
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.5K
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
1.8K
相关概念视频
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
